Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
Johnson and Johnson
Medtronic
Harvard Business School
Colorcon

Last Updated: December 8, 2019

DrugPatentWatch Database Preview

VENOFER Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

When do Venofer patents expire, and what generic alternatives are available?

Venofer is a drug marketed by Am Regent and is included in one NDA.

The generic ingredient in VENOFER is iron sucrose. There are eighty-two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the iron sucrose profile page.

Drug patent expirations by year for VENOFER
Drug Prices for VENOFER

See drug prices for VENOFER

Recent Clinical Trials for VENOFER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Quotient SciencesPhase 1
Baxter Healthcare CorporationPhase 1
University Medical Centre LjubljanaPhase 3

See all VENOFER clinical trials

Pharmacology for VENOFER

US Patents and Regulatory Information for VENOFER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Am Regent VENOFER iron sucrose INJECTABLE;INTRAVENOUS 021135-002 Mar 20, 2005 RX Yes No   Start Trial   Start Trial   Start Trial
Am Regent VENOFER iron sucrose INJECTABLE;INTRAVENOUS 021135-001 Nov 6, 2000 RX Yes Yes   Start Trial   Start Trial   Start Trial
Am Regent VENOFER iron sucrose INJECTABLE;INTRAVENOUS 021135-005 Mar 29, 2013 DISCN No No   Start Trial   Start Trial   Start Trial
Am Regent VENOFER iron sucrose INJECTABLE;INTRAVENOUS 021135-003 Mar 29, 2005 DISCN No No   Start Trial   Start Trial   Start Trial
Am Regent VENOFER iron sucrose INJECTABLE;INTRAVENOUS 021135-004 Feb 9, 2007 RX Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Boehringer Ingelheim
Harvard Business School
Colorcon
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.